Combioxin Overview
- Year Founded
-
2015

- Status
-
Private
- Employees
-
3

- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
Combioxin General Information
Description
Developer of innovative anti-virulence drugs designed to treat severe bacterial infections and combat antibiotic resistance. The company's therapeutic approach consists of using liposomes engineered to neutralize virulence effectors, enabling to restore health in critically ill patients suffering from severe bacterial pneumonia.
Contact Information
Website
www.combioxin.comCorporate Office
- Route de la corniche 8
- 1066 Epalinges
- Switzerland
Corporate Office
- Route de la corniche 8
- 1066 Epalinges
- Switzerland
Combioxin Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Accelerator/Incubator | 01-Jul-2022 | Completed | Clinical Trials - General | |||
2. Accelerator/Incubator | 17-May-2019 | Completed | Startup | |||
1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
Combioxin Patents
Combioxin Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210259967-A1 | Treatment of sepsis and septic shock | Inactive | 20-Apr-2018 | ||
CA-3097045-A1 | Treatment of sepsis and septic shock | Pending | 20-Apr-2018 | ||
AU-2019254640-A1 | Treatment of sepsis and septic shock | Active | 20-Apr-2018 | ||
EP-3781210-A1 | Treatment of sepsis and septic shock | Active | 20-Apr-2018 | ||
JP-2024099554-A | Treatment of sepsis and septic shock | Pending | 20-Apr-2018 | A61K9/127 |
Combioxin Signals
Combioxin Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Fongit | Accelerator/Incubator | Minority | ||
MassChallenge | Accelerator/Incubator | |||
University of Bern | University |
Combioxin FAQs
-
When was Combioxin founded?
Combioxin was founded in 2015.
-
Where is Combioxin headquartered?
Combioxin is headquartered in Epalinges, Switzerland.
-
What is the size of Combioxin?
Combioxin has 3 total employees.
-
What industry is Combioxin in?
Combioxin’s primary industry is Drug Discovery.
-
Is Combioxin a private or public company?
Combioxin is a Private company.
-
What is Combioxin’s current revenue?
The current revenue for Combioxin is
. -
Who are Combioxin’s investors?
Fongit, MassChallenge, and University of Bern have invested in Combioxin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »